The Rise and Fall of SARM1 Base-Exchange Inhibitors
Lundback, T.; Chandrasekar, V.; Gu, C.; Ju, H.; McAdam, R.; Palomero, M.; Sader, K.; Peter, B.; Wissler, L.; Nevin, P.; Foster, E.; Jamier, T.; Manjappa, P.; Johansson, C.; Sandmark, J.; Ding, M.; Persson-Kry, A.; Mitra, S.; Satir, T. M.; Bilican, B.; Messa, M.; Fraser, G.; Linley, J.; Plant, H.; Moore, R.; Seifert, T.; Lerche, M.; Raynochek, C.; Nilsson, E.; Majbour, N.; Lucey, R.; Maia de Oliveira, T.; Wang, Q.; Chessell, I.; Breccia, P.; Jarvis, R.
Show abstract
The sterile alpha and TIR motif containing 1 (SARM1) enzyme is a key driver of axonal degeneration in response to injury, making it an attractive target for treating chemotherapy-induced peripheral neuropathy (CIPN) and other nervous system diseases. In this study, we identified and optimised a new class of base-exchange inhibitors (BEXi) targeting SARM1 and explored their molecular interactions and conformational effects using cryo-EM, HDX-MS and SAXS. Although BEXi produced robust inhibition across all biochemical and cellular assay formats, application at sub-inhibitory concentrations consistently led to paradoxical SARM1 activation, and in neuronal assays, accelerated neurite degeneration. Further analysis showed that BEXi only delayed, rather than prevented, neurite degeneration when applied to primary neuronal cells, even at exceedingly high inhibitor concentrations. These results prompted us to discontinue BEXi development in favour of alternative strategies, underscoring the complexity of SARM1 as a therapeutic target and the need for comprehensive, mechanistically informed screening cascades.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma 97%
- Potent and Selective SETDB1 Covalent Negative Allosteric Modulator Reduces Methyltransferase Activity in Cells 96%
- Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function 96%
Similar papers in this journal
Similar papers in this journal
- Drug Repurposing Screen Identifies an HRI Activating Compound that Promotes Adaptive Mitochondrial Remodeling in MFN2-deficient Cells 95%
- Structural basis for stereospecific inhibition of ASCT2 from rational design 95%
- Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntingtons disease 95%
Similar papers in this journal
Similar papers in this journal
- Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking 95%
- Geometric principles of dendritic integration of excitation and inhibition in cortical neurons 94%
- Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.